Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Total Revenue
172,794
193,718
155,054
170,911
Cost of Revenue
107,477
123,908
95,913
104,383
Gross Profit
65,317
69,810
59,141
66,528
Operating Expenses
Research Development
9,838
9,723
9,810
8,335
Selling General and Administrative
21,649
23,197
20,588
20,553
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
31,487
32,920
30,398
28,888
Operating Income or Loss
33,830
36,890
28,743
37,640
Income from Continuing Operations
Total Other Income/Expenses Net
(341)
(369)
(370,438)
(28,688)
Earnings Before Interest And Taxes
33,489
36,521
(341,695)
8,952
Interest Expense
21,485
21,512
21,433
21,194
Income Before Tax
12,004
15,009
(363,128)
(12,242)
Income Tax Expense
1,359
2,647
(75,600)
(883)
Minority Interest
--
--
--
0
Net Income From Continuing Ops
10,645
12,362
(287,528)
(11,359)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
10,645
12,362
(287,528)
(11,359)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
10,645
12,362
(287,528)
(11,359)